The presence of anxiety-depressive and asthenic disorders in patients with encephalopathy on the background of end-stage chronic renal failure, corrected by programmed hemodialysis

The purpose of the study. To study the frequency, structure and severity of anxiety-depressive and asthenic disorders in patients with encephalopathy on the background of end-stage chronic renal failure (CRF), corrected by programmed hemodialysis.

Materials and methods. 124 patients (71 men and 53 women) aged 40–70 years with end-stage CRF encephalopathy corrected by programmed hemodialysis were examined. Depending on the dialysis experience, they were divided into 2 groups: 67 people with 1–5 years of dialysis experience, 57 people with more than 5 years of dialysis experience. Anxiety (personal and reactive) was recorded using the C. D. Spielberger–Khanin scale, depression was recorded using the T. Beck scale. The structure and severity of asthenia were studied using the MFI-20 questionnaire.

Results. Patients with encephalopathy on the background of chronic kidney disease corrected by programmed hemodialysis were characterized by a high frequency and severity of anxiety-depressive and asthenic disorders, a high polymorbidity index.

1. Chronic Kidney Disease Collaboration. Global, regional and national burden of chronic kidney disease, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. The Lancet. 2023; 402 (10397): 179–204.

2. Bossola M, Vulpio C, Tazza L. Seminars in Dialysis. Postdialysis fatigue: a frequent and debilitating symptom. 2016; 29 (4): 294–301.

3. Yamamoto S, Ito Y, Watanabe Y. et al. Impact of Dialysis Membrane Technology on Asthenia Prevalence: EURO-DOPPS 2024 Update. Kidney Int Rep. 2024; 9 (8): 2341–2352.

4. Zhang X, Liu Y, Wang J. et al. Global Burden of Anxiety in Hemodialysis Patients: A Systematic Review 2024–2025. American J. of Kidney Diseases. 2025; 66 (2): 234–247.

5. Global Dialysis Anxiety Study Collaborative Group. GDAS 2025: Multinational Study of Anxiety Prevalence in Hemodialysis Patients. J of Psychosomatic Research. 2025; 146: 156–172.

6. Chen X, Wang Y, Liu Z. et al. Gender and Age Differences in Anxiety Among Hemodialysis Patients: A Multicenter Cross-Sectional Study. J of Affective Disorders. 2024; 351: 78–91. DOI: 10.1016/j.jad.2024.01.215

7. Robinson BM, Bieber B, Rayner HC. et al. Depression and anxiety in patients on maintenance dialysis: 2025 DOPPS update. Nephrology Dialysis Transplantation. 2025; 40 (3): 441–443.

8. Global Dialysis Depression Study Collaborative Group. GDDS 2025: Multinational Study of Depression Prevalence in Hemodialysis Patients. J of Psychosomatic Research. 2025; 145: 110–125.

9. Yamamoto S, Ito Y, Watanabe Y. et al. Gender and Age Differences in Depression Among Hemodialysis Patients: 2024 Multicenter Analysis. J of Affective Disorders. 2024; 350: 45–53.

10. European Renal Association Dialysis Outcomes Practice Patterns Study. EURO-DOPPS 2024: Depression and Dialysis Parameters. Nephrology Dialysis Transplantation. 2024; 39 (8): 1456–1468.

11. Li Y, Zhang J, Wang H. et al. Global Burden of Depression in Hemodialysis Patients: A Systematic Review and Meta-Analysis 2024–2025. American J of Kidney Diseases. 2025; 65 (3): 345–358.

12. Global Dialysis Outcomes Consortium. GDOS Annual Report 2025: Trends in Symptom Burden Among Hemodialysis Patients. J of Renal Care. 2025; 51 (3): 178–189.

13. Garcia-Lopez E, Carrero JJ, Stenvinkel P. Biomarkers of Asthenia in Contemporary Hemodialysis Practice: A 2025 Perspective. Am J Nephrol. 2025; 46 (1): 45–58.

14. Rodriguez A, Diaz M, Hernandez G. et al. Comorbidity of Anxiety and Depression. Soc Psychiatry Psychiatr Epidemiol. 2025; 60 (2): 234–248.

15. Jhamb M, Weisbord SD, Steel JL, Unruh M. Fatigue in Dialysis Patients. Am J Kidney Dis. 2008; 52 (2): 353–365.

16. Kim H, Park S, Lee K. et al. Biomarkers of Anxiety in Dialysis Рractice. Psychoneuroendocrinology. 2025; 122: 198–210.

17. Chen X, Wang Y, Liu Z. et al. Inflammatory Biomarkers in Depression. Psychoneuroendocrinology. 2025; 120: 104–115.

18. Garcia-Lopez E, Carrero JJ. Stenvinkel P. Contemporary Challenges in Depression Management. Clin Kidney J. 2025; 18 (2): 167–179.

19. Patel S, Kumar M, Sharma P. et al. Economic Burden of Depression. Health Econ Rev. 2025; 15 (1): 67–80.

20. Lazebnik L. B. Aging and polymorbidity. Consilium medicum. 2005; 7 (12):. 993–996. (In Russ.).

21. Spilberger CD, Gorsuch RL, Lushene RE. et al. Manual for the State-Trait Anxiety Inventory. Palo Alto, 1970. 45 р.

22. Beck AT, Ward CH, Henderson H. et al. An inventory for measuring depression. Arch. Gen. Psichiatr. 1961; 5: 561–571.

23. Smets ЕМ. et al. The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. J of Psychosomatic Research. 1995; 39 (3): 315–325.

24. Vershuta VA, Voskresenskaya ON, Tabeeva GR. Emotional and insomnic disorders in patients with headache in chronic cerebral ischemia. RMJ. 2025; 4: 8–11. (In Russ.).

25. Robblee J. Breaking the cycle: unraveling the diagnostic, pathophysiological and treatment challenges of refractory migraine. Front Neurol. 2023. 14. Art. 1263535.

26. Putilina MV. Chronic cerebral ischemia. Lech. doctor. 2005; 6: 28–33. (In Russ.).

27. Putilina M. V. Modern concepts of small vessel disease of the brain. S. S. Korsakov Journal of Neurology and Psychiatry. 2019; 119 (11): 65–73. (In Russ.).

28. Minutko V. L. Depression. M.: GEOTAR-Media, 2006. 320 p. (In Russ.).

29. Andreyko M. F. Dynamics of asthenic syndrome with pathology of the main arteries of the head at the preclinical stage. S. S. Korsakov Journal of Neurology and Psychiatry. 2002; 12: 47–49. (In Russ.).

30. Dyukova G. M. Depression in elderly neurological patients: diagnosis and treatment. Clinical Gerontology. 2008; 3: 67–75. (In Russ.).

31. Tsai Y.-H, Lee M, Lin L.-C. et al. Association of chronic kidney disease with small vessel disease in patients with hypertensive intracerebral hemorrhage. Frontiers in neurology: electronic journal. 2018. 9. URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5946026/

32. Khrulev A. E., Nikitina A. A., Khruleva N. S. Specific risk factors for the development of cerebrovascular disorders in patients with chronic kidney disease in the pre-dialysis period. Cardiovascular Therapy and Prevention. 2019; 18 (3): 88–93. (In Russ.).

33. Khrulev A. E., Shiyanova N. A., Grigorieva V. N. Cerebral microangiopathy according to magnetic resonance imaging of the brain in patients undergoing long-term hemodialysis. Russian Neurological Journal. 2022; 27 (2): 43–52. (In Russ.).

34. Khrulev A. E., Grigorieva V. N., Solovianova E. N., Lineva N. Yu. Risk factors for cerebral vascular disorders and strategies for their correction in patients with chronic kidney disease. Practical Medicine. 2017; 1 (1): 60–64. (In Russ.).